Compression Therapy Companies

The compression therapy market is expected to grow from USD 4.5 billion in 2025 to USD 5.9 billion by 2030, at a CAGR of 5.5% during this period. The global compression therapy market is projected to expand steadily until 2030, driven by the increasing incidence of venous leg ulcers, lymphedema, and post-operative edema. The rising number of cases related to chronic venous disorders and diabetic complications, along with the growing acceptance of compression therapy as a first-line treatment, is boosting product demand in both inpatient and home care settings.

Recent advancements in materials, such as moisture-wicking fabrics, seamless knits, and multilayered bandage systems, improve comfort, adherence, and clinical effectiveness. New technologies include intelligent compression garments equipped with pressure sensors and Bluetooth functionality, enabling real-time monitoring and personalized adjustments. Additionally, the use of 3D printing allows customized compression fits, particularly for complex limb anatomies.

To know about the assumptions considered for the study download the pdf brochure

Market participants are increasingly investing in digital platforms and telehealth-compatible products to support home-based therapy and remote patient monitoring. Compression pumps are enhanced with programmable pressure cycles, compliance monitoring, and improved portability to facilitate their use in outpatient settings. These advancements are shifting the focus of product positioning from traditional garments to integrated therapy solutions.

The major players in the compression therapy market include 3M (US), Essity (Sweden), Medi GmbH & Co. KG (Germany), Sigvaris Group (Switzerland), Tactile Medical (US), Bio Compression Systems (US), AIROS Medical (US), and Arjo (Sweden). The competitive landscape involves analyzing the key growth strategies adopted by these major players from 2021 to 2025 to expand their global presence and increase their market shares.

The primary growth strategies utilized by the leading companies in this market include product launches & approvals, divestitures & acquisitions, collaborations, partnerships, and agreements. In the past three years, product approvals & launches have been the most commonly adopted organic growth strategies by market players aiming to gain a larger share of the market.

BSN Medical (Germany), an Essity company, has strengthened its leadership in global compression therapy through innovation, strategic partnerships, and international expansion. The company continues to enhance its market-leading JOBST range by utilizing advanced technologies such as SoftFit for improved comfort and compliance, sensitive top bands for moisture control, and 3D-knitted seamless garments that provide an anatomical fit, like the JOBST Elvarex Plus.

BSN has reinforced its market position through acquisitions, such as Wright Therapy Products, and collaborations with companies like Terumo Medical Corporation in Japan and Ortopédicos Futuro in Colombia, which have expanded its distribution reach. Additionally, the integration of BSN Medical India into Essity India and the establishment of manufacturing centers in Goa demonstrate the company's commitment to emerging markets and sustainability. These sites operate globally in alignment with Essity's sustainability framework. Other products, such as JOBST Compri2 and the stylish JOBST UltraSheer, reflect BSN's commitment to both clinical performance and consumer preferences, reinforcing its position as a leader in compression therapy.

Medi GmbH & Co. KG (Germany) is a leading manufacturer of medical compression therapy products. The company is well-known for its wide range of medical compression stockings, orthopedic supports, and wound care solutions. Medi serves both clinical and consumer markets under its key brands, Mediven and Circaid, which focus on venous and lymphatic disorders. Medi has a strong presence across Europe, North America, and Asia, with production facilities in Germany and subsidiaries in over 20 countries. The company prioritizes evidence-based product development and uses advanced materials that combine medical effectiveness with patient comfort. Additionally, Medi invests in patient education and digital solutions to promote long-term adherence to therapy.

3M (US) is a leading player in the compression therapy market, known for its clinically validated products that promote wound healing and support vascular health. The company's compression therapy offerings include cohesive bandages, compression wraps, and multi-layer systems, which are widely used in both hospital and home care settings. 3M has a strong global presence across North America, Europe, Asia Pacific, and Latin America. Its solutions effectively address conditions such as venous leg ulcers, lymphedema, and chronic edema. The product line features well-known brands like Coban and ActiWrap, which offer consistent pressure delivery and ease of application. These products are primarily marketed through 3M's Medical Solutions division. 3M emphasizes product innovation and strategic collaborations to maintain its competitive advantage. For example, the company has focused on integrating its products with wound care portfolios and pressure mapping technologies to improve clinical outcomes and enhance the user experience.

Market Ranking:

The compression therapy market is moderately consolidated, with five to six major players accounting for approximately 50–55% of the global market share. 3M leads the market with a diverse portfolio of bandages and wraps suitable for both acute and chronic care. Essity holds a strong position with its JOBST brand, which offers compression garments as well as advanced wound care integration. Medi GmbH & Co. KG and Sigvaris Group are also key players, known for their extensive range of compression stockings and patient-centric solutions. Tactile Medical and AIROS Medical have made significant strides in the pneumatic compression segment by providing innovative home-use therapy devices.

The remaining 45–50% of the market is fragmented among regional manufacturers and niche players who focus on tailored fits, cost-effective alternatives, and novel delivery platforms. This fragmentation encourages innovation and opens opportunities for startups developing smart textiles, app-connected pumps, and telehealth-enabled systems. Market competition is driven by the need for improved patient compliance, ease of use, and data-driven therapy optimization in both clinical and home care settings.

Related Reports:

Compression Therapy Market by Technique (Static, Dynamic), Product (Bandage, Wraps, Stockings, Tapes, Braces, Pneumatic), Application (Varicose Vein, DVT, Lymphedema, Ulcers), Distribution Channel (Clinics, Pharmacy, E-Commerce) - Global Forecasts to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com